Literature DB >> 20499079

Mesopic foveal contrast sensitivity is impaired in diabetic patients without retinopathy.

Gabriel Katz1, Hani Levkovitch-Verbin, Giora Treister, Michael Belkin, Jacob Ilany, Uri Polat.   

Abstract

BACKGROUND: Contrast sensitivity (CS) has been studied extensively to determine its effectiveness as a test for diagnosing early and advanced diabetic retinopathy. Various techniques have been adopted to measure CS, and most of them reported a significant difference between diabetic and normal eyes. Our purpose is to demonstrate differences in foveal CS between diabetic patients without retinopathy and healthy subjects under mesopic and photopic conditions, using a simple, rapid computerized test.
METHODS: Seventeen eyes of nine patients with type 2 diabetes without diabetic retinopathy were included. Fourteen eyes of seven non-diabetic patients served as controls. All the patients underwent a careful ophthalmologic examination, including ETDRS chart visual acuity, color photographs, and optical coherence tomography (OCT). Patients with any ocular disease were excluded. All eyes had a visual acuity of 20/25 or better, a normal eye examination and optical coherence tomography (OCT). Photopic and mesopic contrast sensitivity was tested using a computerized psychophysical static method involving four forced-choice procedures. The targets were Gabor patches with spatial frequencies of 3-12 cycles per degree (cpd). The mesopic testing was conducted in a completely darkened room; the monitor was covered with a neutral density filter, allowing luminance of only 0.9 cd/m(2).
RESULTS: The average age was similar: 59.1 ± 5.3 years in the diabetic group vs 61.4 ± 3.2 years in the control group. The average duration of diabetes was 16 years (range 6-26). The average visual acuity was 0.04 ± 0.01 logMAR and 0.01 ± 0.01 logMAR in the diabetic and control groups respectively. Photopic foveal CS was similar in both groups. Significantly lower CS was found in diabetic patients under mesopic conditions at a spatial frequency of 3 (p < 0.008). At higher spatial frequencies, the mesopic contrast sensitivity was very low in both groups and without a significant difference.
CONCLUSIONS: Mesopic foveal CS is impaired in diabetic patients despite good visual acuity, a normal fundus examination and normal OCT. Early central visual function impairment may occur in diabetic patients before the appearance of retinopathy.

Entities:  

Mesh:

Year:  2010        PMID: 20499079     DOI: 10.1007/s00417-010-1413-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  22 in total

1.  Contrast sensitivity following focal laser photocoagulation in clinically significant macular oedema due to diabetic retinopathy.

Authors:  D Talwar; N Sharma; A Pai; R V Azad; A Kohli; P S Virdi
Journal:  Clin Exp Ophthalmol       Date:  2001-02       Impact factor: 4.207

2.  The scotopic low-frequency spatial contrast sensitivity develops in children between the ages of 5 and 14 years.

Authors:  György Benedek; Krisztina Benedek; Szabolcs Kéri; Márta Janáky
Journal:  Neurosci Lett       Date:  2003-07-24       Impact factor: 3.046

3.  Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus.

Authors:  J M Lopes de Faria; O Katsumi; E Cagliero; D Nathan; T Hirose
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-09       Impact factor: 3.117

4.  Risk factors associated with contrast sensitivity loss in diabetic patients.

Authors:  A A Dosso; E R Bonvin; Y Morel; A Golay; J P Assal; P M Leuenberger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

5.  Are contrast sensitivity functions impaired in insulin dependent diabetics without diabetic retinopathy?

Authors:  V Liska; M Dostálek
Journal:  Acta Medica (Hradec Kralove)       Date:  1999

6.  The contrast sensitivity test in early detection of ocular changes in the relation to the type I diabetes mellitus compensation in children, teenagers, and young adults.

Authors:  Jan Krasny; Michal Andel; Renata Brunnerova; Ilona Cihelkova; Zdenēk Dominek; Jan Lebl; Konstantinos Papadopoulos; Petr Soucek; Ludmila Treslova
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2007-11

7.  Contrast sensitivity in obese dyslipidemic patients with insulin resistance.

Authors:  A A Dosso; F Yenice-Ustun; J Sommerhalder; A Golay; Y Morel; P M Leuenberger
Journal:  Arch Ophthalmol       Date:  1998-10

8.  Psychophysical visual function, retinopathy, and glycemic control in insulin-dependent diabetics with normal visual acuity.

Authors:  O Brinchmann-Hansen; H J Bangstad; S Hultgren; R Fletcher; K Dahl-Jørgensen; K F Hanssen; L Sandvik
Journal:  Acta Ophthalmol (Copenh)       Date:  1993-04

9.  Contrast sensitivity in diabetic retinopathy after panretinal photocoagulation.

Authors:  P K Khosla; V Rao; H K Tewari; A Kumar
Journal:  Ophthalmic Surg       Date:  1994-08

10.  Relationship between contrast sensitivity and metabolic control in diabetics with and without retinopathy.

Authors:  A Verrotti; L Lobefalo; M T Petitti; L Mastropasqua; G Morgese; F Chiarelli; P E Gallenga
Journal:  Ann Med       Date:  1998-08       Impact factor: 4.709

View more
  12 in total

1.  Study of Retinal Nerve Fibre Layer Thickness in Patients with Diabetes Mellitus Using Fourier Domain Optical Coherence Tomography.

Authors:  Renu Dhasmana; Sonal Sah; Neeti Gupta
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Comparing the Impact of Refractive and Nonrefractive Vision Loss on Functioning and Disability: The Salisbury Eye Evaluation.

Authors:  Nazlee Zebardast; Bonnielin K Swenor; Suzanne W van Landingham; Robert W Massof; Beatriz Munoz; Sheila K West; Pradeep Y Ramulu
Journal:  Ophthalmology       Date:  2015-03-24       Impact factor: 12.079

Review 3.  Psychophysical Exams as Early Indicators of Diabetic Retinopathy.

Authors:  Nicola Pescosolido; Giuseppe Buomprisco
Journal:  Eur Endocrinol       Date:  2014-02-28

4.  The effects of early diabetes on inner retinal neurons.

Authors:  Erika D Eggers; Teresia A Carreon
Journal:  Vis Neurosci       Date:  2020-09-16       Impact factor: 3.241

5.  Effect of diabetic retinopathy and diabetes on the intraocular straylight in pseudophakic eyes.

Authors:  Hyung Bin Hwang; Hye Bin Yim; Sung Kun Chung
Journal:  BMC Ophthalmol       Date:  2015-10-13       Impact factor: 2.209

6.  Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab.

Authors:  Donald R Nixon; Nicholas Ap Flinn
Journal:  Clin Ophthalmol       Date:  2018-01-22

7.  Spatial visual function in anomalous trichromats: Is less more?

Authors:  Ravid Doron; Anna Sterkin; Moshe Fried; Oren Yehezkel; Maria Lev; Michael Belkin; Mordechai Rosner; Arieh S Solomon; Yossi Mandel; Uri Polat
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

Review 8.  A critical review: Psychophysical assessments of diabetic retinopathy.

Authors:  Xing D Chen; Thomas W Gardner
Journal:  Surv Ophthalmol       Date:  2020-08-29       Impact factor: 6.048

9.  Multidimensional Functional and Structural Evaluation Reveals Neuroretinal Impairment in Early Diabetic Retinopathy.

Authors:  Katherine A Joltikov; Vinicius M de Castro; Jose R Davila; Rohit Anand; Sami M Khan; Neil Farbman; Gregory R Jackson; Chris A Johnson; Thomas W Gardner
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-05-01       Impact factor: 4.799

10.  Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice.

Authors:  Moon K Kim; Moe H Aung; Lukas Mees; Darin E Olson; Nikita Pozdeyev; P Michael Iuvone; Peter M Thule; Machelle T Pardue
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.